These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 25061306)

  • 1. The effects of electroconvulsive therapy on tardive dystonia or dyskinesia induced by psychotropic medication: a retrospective study.
    Yasui-Furukori N; Kikuchi A; Katagai H; Kaneko S
    Neuropsychiatr Dis Treat; 2014; 10():1209-12. PubMed ID: 25061306
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Successful Electroconvulsive Therapy for Tardive Dyskinesia and Tardive Dystonia Refractory to Valbenazine Treatment: A Case Report and Narrative Literature Review.
    Irinaka K; Itoh Y; Yoshizawa K; Ogasawara M; Ayabe N; Mishima K; Takeshima M
    Clin Psychopharmacol Neurosci; 2024 Nov; 22(4):688-696. PubMed ID: 39420617
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tardive dystonia, catatonia, and electroconvulsive therapy.
    Kwentus JA; Schulz SC; Hart RP
    J Nerv Ment Dis; 1984 Mar; 172(3):171-3. PubMed ID: 6142087
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Abnormal involuntary movement scale in tardive dyskinesia: Minimal clinically important difference.
    Stacy M; Sajatovic M; Kane JM; Cutler AJ; Liang GS; O'Brien CF; Correll CU
    Mov Disord; 2019 Aug; 34(8):1203-1209. PubMed ID: 31234240
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of tardive dyskinesia, tardive dystonia, and respiratory dyskinesia among Chinese psychiatric patients in Hong Kong.
    Chiu H; Shum P; Lau J; Lam L; Lee S
    Am J Psychiatry; 1992 Aug; 149(8):1081-5. PubMed ID: 1353316
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Electroconvulsive Therapy as a Treatment for Tardive Dyskinesia.
    Yahya AS; Khawaja S
    Prim Care Companion CNS Disord; 2021 May; 23(3):. PubMed ID: 34000170
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tardive dyskinesia and tardive dystonia with second-generation antipsychotics in non-elderly schizophrenic patients unexposed to first-generation antipsychotics: a cross-sectional and retrospective study.
    Ryu S; Yoo JH; Kim JH; Choi JS; Baek JH; Ha K; Kwon JS; Hong KS
    J Clin Psychopharmacol; 2015 Feb; 35(1):13-21. PubMed ID: 25485636
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of clozapine in tardive dystonia.
    Van Harten PN; Kampuis DJ; Matroos GE
    Prog Neuropsychopharmacol Biol Psychiatry; 1996 Feb; 20(2):263-74. PubMed ID: 8861192
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The prevalence of tardive dystonia, tardive dyskinesia, parkinsonism and akathisia The Curaçao Extrapyramidal Syndromes Study: I.
    van Harten PN; Matroos GE; Hoek HW; Kahn RS
    Schizophr Res; 1996 May; 19(2-3):195-203. PubMed ID: 8789918
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deep brain stimulation for tardive syndromes: Systematic review and meta-analysis.
    Macerollo A; Deuschl G
    J Neurol Sci; 2018 Jun; 389():55-60. PubMed ID: 29433807
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risperidone for pre-existing severe tardive dyskinesia: a 48-week prospective follow-up study.
    Bai YM; Yu SC; Chen JY; Lin CY; Chou P; Lin CC
    Int Clin Psychopharmacol; 2005 Mar; 20(2):79-85. PubMed ID: 15729082
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A review of 32 cases of tardive dystonia.
    Wojcik JD; Falk WE; Fink JS; Cole JO; Gelenberg AJ
    Am J Psychiatry; 1991 Aug; 148(8):1055-9. PubMed ID: 1677236
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An open-label study of botulinum toxin A for treatment of tardive dystonia.
    Tarsy D; Kaufman D; Sethi KD; Rivner MH; Molho E; Factor S
    Clin Neuropharmacol; 1997 Feb; 20(1):90-3. PubMed ID: 9037579
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risperidone for severe tardive dyskinesia: a 12-week randomized, double-blind, placebo-controlled study.
    Bai YM; Yu SC; Lin CC
    J Clin Psychiatry; 2003 Nov; 64(11):1342-8. PubMed ID: 14658949
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tardive dystonia and severe tardive dyskinesia. A comparison of risk factors and prognosis.
    Giménez-Roldán S; Mateo D; Bartolomé P
    Acta Psychiatr Scand; 1985 May; 71(5):488-94. PubMed ID: 2861717
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of tardive dyskinesia and tardive dystonia with clozapine: A retrospective study.
    Grover S; Chaurasia N; Chakrabarti S
    Asian J Psychiatr; 2024 Sep; 102():104245. PubMed ID: 39288640
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Prevention and treatment of tardive dyskinesia caused by antipsychotic drugs].
    Seigneurie AS; Sauvanaud F; Limosin F
    Encephale; 2016 Jun; 42(3):248-54. PubMed ID: 26922134
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Managing antipsychotic-induced tardive dyskinesia.
    Gardos G
    Drug Saf; 1999 Feb; 20(2):187-93. PubMed ID: 10082074
    [TBL] [Abstract][Full Text] [Related]  

  • 19. KINECT 3: A Phase 3 Randomized, Double-Blind, Placebo-Controlled Trial of Valbenazine for Tardive Dyskinesia.
    Hauser RA; Factor SA; Marder SR; Knesevich MA; Ramirez PM; Jimenez R; Burke J; Liang GS; O'Brien CF
    Am J Psychiatry; 2017 May; 174(5):476-484. PubMed ID: 28320223
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determining Whether a Definitive Causal Relationship Exists Between Aripiprazole and Tardive Dyskinesia and/or Dystonia in Patients With Major Depressive Disorder, Part 3: Clinical Trial Data.
    Preskorn SH; Macaluso M
    J Psychiatr Pract; 2016 Mar; 22(2):117-23. PubMed ID: 27138080
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.